SAGIMET BIOSCIENCES INC-A (SGMT)

US7867001049 - Common Stock

5.42  +0.09 (+1.69%)

After market: 5.38 -0.04 (-0.74%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to SGMT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 33.25. This target is 513.51% above the current price.
SGMT was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SGMT.
In the previous month the buy percentage consensus was at a similar level.
SGMT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 5.426.0632.6433.2570.35 - 11.81% 502.21% 513.51% 1,197.97%
Up and Down Grades
Date Firm Action Rating
2024-10-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-02 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-15 JMP Securities Maintains Market Outperform -> Market Outperform
2024-08-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-01 Goldman Sachs Maintains Neutral -> Neutral
2024-06-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-07 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-06-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-24 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-05-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-16 Goldman Sachs Maintains Buy -> Buy
2024-05-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-02 HC Wainwright & Co. Initiate Buy
2024-03-26 Goldman Sachs Maintains Buy -> Buy
2024-03-25 Leerink Partners Initiate Outperform
2024-02-07 JMP Securities Maintains Market Outperform -> Market Outperform
2024-01-23 JMP Securities Maintains Market Outperform -> Market Outperform
2024-01-23 Goldman Sachs Maintains Buy -> Buy
2024-01-22 JMP Securities Maintains Market Outperform -> Market Outperform
2023-12-05 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-08-08 TD Cowen Initiate Outperform
2023-08-08 JMP Securities Initiate Market Outperform
2023-08-08 Goldman Sachs Initiate Buy
2023-08-08 Piper Sandler Initiate Overweight